Articles By Anuja Singh
How Is Caltech’s AI Smart Bandage Set to Reshape $20B Global Wound Care Market?…
Key Highlights Smart Bandage Breakthrough: A Strategic AI-Driven Platform from CaltechIn a landmark step toward intelligent wound management,…
By
Can Bayer’s Partnership with Altis Labs’ AI Boost Lung Cancer Trial Accuracy by 50%?…
Altis’ IPRO-Δ AI model outperforms RECIST in predicting survival, signaling a major shift in oncology trial endpoint Altis-Bayer…
Is IBM and Inclusive Brains’ AI-Quantum Fusion the Key to Unlocking Personalized Brain-Machine Interfaces…
Key Highlights Advancing Accessibility Through Multimodal AI and Brain-Machine InterfacesThe collaboration aims to improve the classification accuracy of…
AI at the FDA: Will ‘Elsa’ Redefine How the U.S. Accelerates Biopharma Drug Reviews?
Key highlights Regulatory AI Disruption: Why the FDA’s ‘Elsa’ Tool Is a Gamechanger for Biopharma The U.S. Food…
AI in Pharmacovigilance: Why Are Top Global Biopharma Leaders Choosing ArisGlobal’s NavaX to Scale…
Key Highlights Industry Confidence Grows as NavaX Gains MomentumArisGlobal, a leader in life sciences technology, has announced the…
Can the FDA’s Elsa AI Transform Medical Device Oversight and Safeguard 330 Million Americans?
Key Takeaways Transforming the FDA’s Mission With Secure Generative AIIn a landmark step toward modernizing regulatory science, the…
How Is Caltech’s AI Smart Bandage Set to Reshape $20B Global Wound Care Market?…
Key Highlights Smart Bandage Breakthrough: A Strategic AI-Driven Platform from CaltechIn a landmark step toward intelligent wound management,…
Can Bayer’s Partnership with Altis Labs’ AI Boost Lung Cancer Trial Accuracy by 50%?…
Altis’ IPRO-Δ AI model outperforms RECIST in predicting survival, signaling a major shift in oncology trial endpoint Altis-Bayer…
Is IBM and Inclusive Brains’ AI-Quantum Fusion the Key to Unlocking Personalized Brain-Machine Interfaces…
Key Highlights Advancing Accessibility Through Multimodal AI and Brain-Machine InterfacesThe collaboration aims to improve the classification accuracy of…
AI at the FDA: Will ‘Elsa’ Redefine How the U.S. Accelerates Biopharma Drug Reviews?
Key highlights Regulatory AI Disruption: Why the FDA’s ‘Elsa’ Tool Is a Gamechanger for Biopharma The U.S. Food…
AI in Pharmacovigilance: Why Are Top Global Biopharma Leaders Choosing ArisGlobal’s NavaX to Scale…
Key Highlights Industry Confidence Grows as NavaX Gains MomentumArisGlobal, a leader in life sciences technology, has announced the…
Can the FDA’s Elsa AI Transform Medical Device Oversight and Safeguard 330 Million Americans?
Key Takeaways Transforming the FDA’s Mission With Secure Generative AIIn a landmark step toward modernizing regulatory science, the…